Literature DB >> 17604631

'Bridged' stilbene derivatives as selective cyclooxygenase-1 inhibitors.

Norbert Handler1, Gerda Brunhofer, Christian Studenik, Klaus Leisser, Walter Jaeger, Stephanie Parth, Thomas Erker.   

Abstract

Resveratrol ((E)-3,4',5-trihydroxy-stilbene), a phytoalexin found in various plants, shows non-selective cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2) inhibition. In order to find more selective COX inhibitors a series of bridged stilbene derivatives was synthesized and evaluated for their ability to inhibit both COX-1 and COX-2 in vitro. The compounds showed a high rate of COX-1 inhibition with the most potent compounds exhibiting submicromolar IC(50) values and high selectivity indices. A prediction model for COX-inhibiting activity was also developed using the classical LIE approach resulting in consistent docking data for our molecule sample. Phenyl substituted 1,2-dihydronaphthalene derivatives and 1H-indene derivatives therefore represent a novel class of highly selective COX-1 inhibitors and land promising candidates for in vivo studies.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17604631     DOI: 10.1016/j.bmc.2007.06.030

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  6 in total

1.  Molecular dynamics simulation and linear interaction energy study of D-Glu-based inhibitors of the MurD ligase.

Authors:  Andrej Perdih; Gerhard Wolber; Tom Solmajer
Journal:  J Comput Aided Mol Des       Date:  2013-08-30       Impact factor: 3.686

2.  Antineoplastic agents. 579. Synthesis and cancer cell growth evaluation of E-stilstatin 3: a resveratrol structural modification.

Authors:  George R Pettit; Noeleen Melody; Andrew Thornhill; John C Knight; Thomas L Groy; Cherry L Herald
Journal:  J Nat Prod       Date:  2009-09       Impact factor: 4.050

3.  Binding free energy calculations of N-sulphonyl-glutamic acid inhibitors of MurD ligase.

Authors:  Andrej Perdih; Urban Bren; Tom Solmajer
Journal:  J Mol Model       Date:  2009-02-06       Impact factor: 1.810

Review 4.  Therapeutic potentials of resveratrol in combination with radiotherapy and chemotherapy during glioblastoma treatment: a mechanistic review.

Authors:  AmirAhmad Arabzadeh; Tohid Mortezazadeh; Tayebeh Aryafar; Esmaeil Gharepapagh; Mehrsa Majdaeen; Bagher Farhood
Journal:  Cancer Cell Int       Date:  2021-07-21       Impact factor: 5.722

Review 5.  Polypharmacology or Promiscuity? Structural Interactions of Resveratrol With Its Bandwagon of Targets.

Authors:  Uzma Saqib; Tanya T Kelley; Siva K Panguluri; Dongfang Liu; Rajkumar Savai; Mirza S Baig; Stephan C Schürer
Journal:  Front Pharmacol       Date:  2018-10-24       Impact factor: 5.810

6.  A Systematic Review of the Potential Chemoprotective Effects of Resveratrol on Doxorubicin-Induced Cardiotoxicity: Focus on the Antioxidant, Antiapoptotic, and Anti-Inflammatory Activities.

Authors:  Li-Feng Hu; Huan-Rong Lan; Xue-Min Li; Ke-Tao Jin
Journal:  Oxid Med Cell Longev       Date:  2021-08-22       Impact factor: 6.543

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.